Virtual Conferences

MarketsandMarkets Plant Based and Alternative Protein Virtual Conference

MarketsandMarkets Plant Based and Alternative Protein Virtual Conference
17th -18th October 2022

Plant-based foods are one of the fastest growing food categories, growing by double digits in 2019, and are expected to reach $68.4 billion worldwide by 2026. The growth of this market is driven by a wide range of factors, including the increasing intolerance for animal proteins among consumers, the growing vegan population, and the booming number of venture investments in plant-based foods. Further, the increasing number of new products developed by manufacturers of plant-based proteins and emerging economies, such as Asian-Pacific, Latin America, and Middle East & Africa, are expected to provide new opportunities for players in this market.


MarketsandMarkets Next-Gen Agritech Virtual Conference (Time Zone - EST)

MarketsandMarkets Next-Gen Agritech Virtual Conference (Time Zone - EST)
17th - 18th October 2022

Emerging agricultural trends involve new technologies and strategies that become more advanced over time. There have been significant changes in the agriculture sector over the past several decades and new technologies have also been introduced. All these factors have led to an expansion of the sector. Recent agricultural advances have made farming activities more comfortable and acceptable for farmers. Developments or trends such as these benefit not only the growth of agriculture, but also the lives of farmers.


3rd Annual MarketsandMarkets World Pharma Supply Chain and Cold Chain Logistics Virtual Conference (Time zone- Eastern Standard Time )

3rd Annual MarketsandMarkets World Pharma Supply Chain and Cold Chain Logistics Virtual Conference (Time zone-  Eastern Standard Time )
20th-21st October 2022

MarketsandMarkets is proud to announce the 3rd Annual MarketsandMarkets World Pharma Supply Chain and Cold Chain Logistics Virtual Conference on 20th-21st October 2022

Pharmaceutical supply chain and logistics faced the hardest disruptions during initial COVID era. Now, with COVID therapeutic manufacturing taking space, there also is a big desire to accelerate other clinical pipeline because of the ample opportunity for new medicine. While some companies were able to cope with their contingencies plan in place, the other followed risk mitigation. It is now essential for the pharma supply chain and logistics to follow the redundancy routes.